NKG2A blockade as a potential strategy to improve NK cell-mediated ADCC in HER2+ breast cancer 

Suárez Olmos, Jesús (Date of defense: 2023-11-30)

Several studies support the contribution of antibody-dependent NK cell cytotoxicity (ADCC) to the clinical efficacy of anti-HER2 therapeutic antibodies in HER2-positive breast cancer. Novel anti-HER2 antibody drug conjugates ...